Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal

J Am Coll Surg. 2008 Jul;207(1):95-105. doi: 10.1016/j.jamcollsurg.2008.01.024. Epub 2008 May 23.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Cancer Vaccines / immunology
  • Clinical Trials, Phase III as Topic
  • Dacarbazine / therapeutic use
  • Dendritic Cells / immunology
  • Epitopes / immunology
  • Gangliosides / immunology
  • Immunotherapy, Active / methods*
  • Interferons / therapeutic use
  • Melanoma / immunology
  • Melanoma / therapy*
  • Vaccinia virus / immunology

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Cancer Vaccines
  • Epitopes
  • Gangliosides
  • Dacarbazine
  • Interferons